The Number of Mesogastria Containing Metastatic Lymph Nodes Predicts Gastric Cancer Prognosis

NCT06697821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2024-11-25

No results posted yet for this study

Summary

To investigate the impact of the number of mesogastria containing metastatic lymph nodes on the prognosis of gastric cancer.

Conditions

Interventions

PROCEDURE

D2+CME

Whether to perform the whole mesogastric excision

Sponsors & Collaborators

  • Jichao Qin

    lead OTHER

Principal Investigators

  • Jichao Qin, M.D./Ph.D · Huazhong University of Science and Technology

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2023-05-01
Completion
2024-05-01

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06697821 on ClinicalTrials.gov